|
US2020216511A1
|
|
Highly purified recombinant human insulin (rhi) api and methods of producing the same
|
|
US2017196941A1
|
|
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
|
|
CA2954287A1
|
|
Methods of preparing inhalable micronized insulin for pulmonary delivery
|
|
US2016096808A1
|
|
Methods of resolving racemic mixture to obtain (−)-huperzine A
|
|
US2016096816A1
|
|
Method of preparing intermediate of salmeterol
|
|
US2016096856A1
|
|
Method of purifying idraparinux sodium
|
|
US9303060B1
|
|
Methods of preparing intermediate of fluticasone propionate
|
|
US8367734B1
|
|
Stable epinephrine suspension formulation with high inhalation delivery efficiency
|
|
CN101616591A
|
|
Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
|
|
WO2007079252A2
|
|
Sustained release pharmaceutical compositions
|
|
US7219816B1
|
|
Easily sealed and opened pre-filled, disposable pipette
|
|
US7468394B1
|
|
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
|
|
US6827479B1
|
|
Uniform small particle homogenizer and homogenizing process
|
|
US6793076B1
|
|
Glass bottle protective enclosure
|
|
EP1252075A1
|
|
Pre-filled disposable pipettes
|
|
US6457612B1
|
|
Sealable and manipulable pre-filled disposable pipette
|
|
US6399087B1
|
|
Propofol formulation with enhanced microbial inhibition
|
|
US6418982B1
|
|
Process of bulk filling
|
